SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Pablo Barreiro, José Vicente Fernández-Montero, Carmen de Mendoza, Pablo Labarga, Vincent Soriano, Pharmacogenetics of antiretroviral therapy, Expert Opinion on Drug Metabolism & Toxicology, 2014, 1

    CrossRef

  2. 2
    S. Vardhanabhuti, E. P. Acosta, H. J. Ribaudo, P. Severe, U. Lalloo, N. Kumarasamy, F. Taulo, J. Kabanda, O. Oneko, P. Ive, P. Sambarey, E. S. Chan, J. Hitti, F. Hong, D. McMahon, D. W. Haas, Clinical and Genetic Determinants of Plasma Nevirapine Exposure Following an Intrapartum Dose to Prevent Mother-to-Child HIV Transmission, Journal of Infectious Diseases, 2013, 208, 4, 662

    CrossRef

  3. 3
    Ulrich M. Zanger, Matthias Schwab, Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation, Pharmacology & Therapeutics, 2013, 138, 1, 103

    CrossRef

  4. 4
    Marco Siccardi, Rajith Kumar Reddy Rajoli, Paul Curley, Adeniyi Olagunju, Darren Moss, Andrew Owen, Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective, Future Virology, 2013, 8, 9, 871

    CrossRef

  5. 5
    Neill J. Liptrott, Sudeep Pushpakom, Christoph Wyen, Gerd Fätkenheuer, Christian Hoffmann, Stefan Mauss, Heribert Knechten, Norbert H. Brockmeyer, Elizabeth Hopper-Borge, Marco Siccardi, David J. Back, Saye H. Khoo, Munir Pirmohamed, Andrew Owen, Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDS, Pharmacogenetics and Genomics, 2012, 22, 1, 10

    CrossRef

  6. 6
    Sandra G. Heil, Marchina E. van der Ende, Paul W. Schenk, Ilse van der Heiden, Jan Lindemans, David Burger, Ron H. N. van Schaik, Associations Between ABCB1, CYP2A6, CYP2B6, CYP2D6, and CYP3A5 Alleles in Relation to Efavirenz and Nevirapine Pharmacokinetics in HIV-Infected Individuals, Therapeutic Drug Monitoring, 2012, 34, 2, 153

    CrossRef

  7. 7
    Kevin C Brown, Mina C Hosseinipour, Janelle M Hoskins, Ranjit K Thirumaran, Hsiao-Chuan Tien, Ralf Weigel, Jean Tauzie, Ida Shumba, Jatinder K Lamba, Erin G Schuetz, Howard L McLeod, Angela DM Kashuba, Amanda H Corbett, Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians, Pharmacogenomics, 2012, 13, 1, 113

    CrossRef

  8. 8
    Rebecca Pavlos, Simon Mallal, Elizabeth Phillips, HLA and pharmacogenetics of drug hypersensitivity, Pharmacogenomics, 2012, 13, 11, 1285

    CrossRef

  9. 9
    Julie Bertrand, Monidarin Chou, Danielle M. Richardson, Céline Verstuyft, Paul D. Leger, France Mentré, Anne-Marie Taburet, David W. Haas, Multiple genetic variants predict steady-state nevirapine clearance in HIV-infected Cambodians, Pharmacogenetics and Genomics, 2012, 22, 12, 868

    CrossRef

  10. 10
    Jing Li, Vincent Menard, Rebekah L Benish, Richard J Jurevic, Chantal Guillemette, Mark Stoneking, Peter A Zimmerman, Rajeev K Mehlotra, Worldwide variation in human drug-metabolism enzyme genesCYP2B6andUGT2B7: implications for HIV/AIDS treatment, Pharmacogenomics, 2012, 13, 5, 555

    CrossRef

  11. 11
    Natella Y. Rakhmanina, Charles J.L. la Porte, Therapeutic Drug Monitoring, 2012,

    CrossRef

  12. 12
    Sofia A. Pereira, Riccardo Wanke, M. Matilde Marques, Emília C. Monteiro, Alexandra M.M. Antunes, Advances in Molecular Toxicology Volume 6, 2012,

    CrossRef

  13. 13
    Mona Arab-Alameddine, Laurent Arhtur Décosterd, Thierry Buclin, Amalio Telenti, Chantal Csajka, Antiretroviral drug toxicity in relation to pharmacokinetics, metabolic profile and pharmacogenetics, Expert Opinion on Drug Metabolism & Toxicology, 2011, 7, 5, 609

    CrossRef

  14. 14
    R. K. Mehlotra, V. K. Cheruvu, M. J. Blood Zikursh, R. L. Benish, M. M. Lederman, R. A. Salata, B. Gripshover, G. A. McComsey, M. V. Lisgaris, S. Fulton, C. S. Subauste, R. J. Jurevic, C. Guillemette, P. A. Zimmerman, B. Rodriguez, Chemokine (C-C Motif) Receptor 5 -2459 Genotype in Patients Receiving Highly Active Antiretroviral Therapy: Race-Specific Influence on Virologic Success, Journal of Infectious Diseases, 2011, 204, 2, 291

    CrossRef

  15. 15
    Tanya Welz, Kate Childs, Frank A Post, Do nevirapine and efavirenz affect vitamin D homeostasis similarly?, AIDS, 2011, 25, 6, 875

    CrossRef

  16. 16
    S. Swaminathan, G. Ramachandran, H. K. Agibothu Kupparam, V. Mahalingam, L. Soundararajan, B. Perumal Kannabiran, P. G. D. Navaneethapandian, I. Shah, R. Karunaianandham, R. Sikhamani, Factors influencing plasma nevirapine levels: a study in HIV-infected children on generic antiretroviral treatment in India, Journal of Antimicrobial Chemotherapy, 2011, 66, 6, 1354

    CrossRef

  17. You have full text access to this OnlineOpen article17
    Mas Chaponda, Munir Pirmohamed, Hypersensitivity reactions to HIV therapy, British Journal of Clinical Pharmacology, 2011, 71, 5
  18. 18
    A. Schipani, C. Wyen, T. Mahungu, H. Hendra, D. Egan, M. Siccardi, G. Davies, S. Khoo, G. Fatkenheuer, M. Youle, J. Rockstroh, N. H. Brockmeyer, M. A. Johnson, A. Owen, D. J. Back, Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals, Journal of Antimicrobial Chemotherapy, 2011, 66, 6, 1332

    CrossRef

  19. 19
    Jean-Jacques Parienti, Gilles Peytavin, Nevirapine once daily: pharmacology, metabolic profile and efficacy data of the new extended-release formulation, Expert Opinion on Drug Metabolism & Toxicology, 2011, 7, 4, 495

    CrossRef

  20. 20
    M. Lamorde, P. Byakika-Kibwika, V. Okaba-Kayom, M. Ryan, P. Coakley, M. Boffito, R. Namakula, F. Kalemeera, R. Colebunders, D. Back, S. Khoo, C. Merry, Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin, Journal of Antimicrobial Chemotherapy, 2011, 66, 1, 180

    CrossRef

  21. 21
    Claire Gozalo, Laurence Gérard, Pascale Loiseau, Laurence Morand-Joubert, Gilles Peytavin, Jean-Michel Molina, Pierre Dellamonica, Laurent Becquemont, Jean-Pierre Aboulker, Odile Launay, Céline Verstuyft, Pharmacogenetics of Toxicity, Plasma Trough Concentration and Treatment Outcome with Nevirapine-Containing Regimen in Anti-Retroviral-Naïve HIV-Infected Adults: An Exploratory Study of the TRIANON ANRS 081 Trial, Basic & Clinical Pharmacology & Toxicology, 2011, 109, 6
  22. 22
    David W. Haas, Daniel R. Kuritzkes, Marylyn D. Ritchie, Shashi Amur, Brian F. Gage, Gary Maartens, Dan Masys, Jacques Fellay, Elizabeth Phillips, Heather J. Ribaudo, Kenneth A. Freedberg, Christos Petropoulos, Teri A. Manolio, Roy M. Gulick, Richard Haubrich, Peter Kim, Marjorie Dehlinger, Rahel Abebe, Amalio Telenti, Pharmacogenomics of HIV Therapy: Summary of a Workshop Sponsored by the National Institute of Allergy and Infectious Diseases, HIV Clinical Trials, 2011, 12, 5, 277

    CrossRef

  23. 23
    Jing Yuan, Sheng Guo, David Hall, Anna M Cammett, Supriya Jayadev, Manuel Distel, Stephen Storfer, Zimei Huang, Piroon Mootsikapun, Kiat Ruxrungtham, Daniel Podzamczer, David W Haas, Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent, AIDS, 2011, 25, 10, 1271

    CrossRef

  24. 24
    Tabitha Mahungu, Andrew Owen, Genetics and Evolution of Infectious Disease, 2011,

    CrossRef

  25. 25
    Jun Chen, Jianjun Sun, Qing Ma, Yaming Yao, Zhenyan Wang, Lijun Zhang, Li Li, Fuyan Sun, Hongzhou Lu, CYP2B6 Polymorphism and Nonnucleoside Reverse Transcriptase Inhibitor Plasma Concentrations in Chinese HIV-Infected Patients, Therapeutic Drug Monitoring, 2010, 32, 5, 573

    CrossRef

  26. 26
    Mohammed Lamorde, Pauline Byakika-Kibwika, Violet Okaba-Kayom, John P Flaherty, Marta Boffito, Rhoda Namakula, Mairin Ryan, Clemensia Nakabiito, David J Back, Saye Khoo, Concepta Merry, Kimberly K Scarsi, Suboptimal Nevirapine Steady-State Pharmacokinetics During Intrapartum Compared With Postpartum in HIV-1-Seropositive Ugandan Women, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2010, 55, 3, 345

    CrossRef

  27. 27
    S. Chantarangsu, T. R. Cressey, S. Mahasirimongkol, E. Capparelli, Y. Tawon, N. Ngo-Giang-Huong, G. Jourdain, M. Lallemant, W. Chantratita, Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women, Journal of Antimicrobial Chemotherapy, 2009, 64, 6, 1265

    CrossRef

  28. 28
    Natella Y. Rakhmanina, John N. van den Anker, Pharmacogenomic Aspects of Antiretroviral Therapy,